Evidence map›Paper›PMID 26950361›Full record

ArticleNature medicine2016

A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance.

Cholsoon Jang, Sungwhan F Oh, Shogo Wada, Glenn C Rowe, Laura Liu, Mun Chun Chan, James Rhee, Atsushi Hoshino, Boa Kim, Ayon Ibrahim and 14 more

Open access · greenAbstract read
In one paragraph

Article in Nature medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 375 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
375citing papers in PubMed, 2 pooled it
31.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

375 citing papers in PubMed, 2 syntheses or guidelines pooled it, 567 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. The emerging role of branched-chain amino acid metabolism in obesity.International journal of obesity (2005) · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

315 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 1 country.

Cholsoon JangPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sungwhan F OhDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Shogo WadaPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Glenn C RoweBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Laura LiuBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Mun Chun ChanBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
James RheeBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Atsushi HoshinoPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Boa KimPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ayon IbrahimPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Luisa G BacaBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Esl KimBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Chandra C GhoshBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Samir M ParikhBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Aihua JiangBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Qingwei ChuPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Daniel E FormanDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Stewart H LeckerBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Saikumari KrishnaiahPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Joshua D RabinowitzLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey, USA.
Aalim M WeljiePerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Joseph A BaurPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Dennis L KasperDepartment of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA.
Zoltan AranyPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Harvard University · USUniversity of Pennsylvania · USBeth Israel Deaconess Medical Center · USPrinceton University · USUniversity of Pittsburgh · US

Funding

VIRAL VECTOR COREP30DK019525 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI DOUGLAS J EPSTEIN · 1986 to 2026
$48.3M
Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FLOREZ, JOSE CARLOS · 2000 to 2019
$31.4M
ZINC FINGER PROTEINS IN EARLY KIDNEY DEVELOPMENTP01DK049210 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KAESTNER, KLAUS H · 1995 to 2016
$26.9M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Research Training for AnesthetistsT32GM007592 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI STUART A FORMAN · 1985 to 2026
$11.8M
Training Program in Cardiovascular ResearchT32HL007374 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MITTLEMAN, MURRAY A · 1985 to 2019
$7.9M
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and AgingR01DK098656 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Joseph A. Baur · 2013 to 2026
$6.1M
Mitochondrial Biogenesis in Kidney DiseaseR01DK095072 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Samir M Parikh · 2012 to 2026
$5.3M
Biology of Tie2 in sepsisR01HL093234 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI PARIKH, SAMIR M · 2008 to 2017
$4.6M
Targeting the Endothelium in SepsisR01HL125275 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FLAUMENHAFT, ROBERT C, PARIKH, SAMIR M · 2014 to 2018
$4.2M
PGC-1 Coactivators in Muscle Angiogenesis IschemiaR01HL094499 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI ARANY, ZOLTAN P · 2010 to 2018
$3.7M
Molecular Mechanisms of Rapamycin's Effects on Health and LongevityR01AG043483 · NIA · UNIVERSITY OF PENNSYLVANIA · PI BAUR, JOSEPH A. · 2013 to 2017
$2.0M
NHLBI NIH HHS HL093234NHLBI NIH HHS HL094499NHLBI NIH HHS HL125275NHLBI NIH HHS R01 HL093234NHLBI NIH HHS R01 HL094499NHLBI NIH HHS R01 HL125275NHLBI NIH HHS T32 HL007374NIAID NIH HHS T32 AI007061NIAMS NIH HHS AR062128NIAMS NIH HHS K01 AR062128NIA NIH HHS R01 AG043483NIDDK NIH HHS DK049210NIDDK NIH HHS DK095072NIDDK NIH HHS DK098656NIDDK NIH HHS K01 DK102771NIDDK NIH HHS P01 DK049210NIDDK NIH HHS P30 DK019525NIDDK NIH HHS P30 DK057521NIDDK NIH HHS R01 DK095072NIDDK NIH HHS R01 DK098656NIGMS NIH HHS 5 T32 GM7592-35NIGMS NIH HHS T32 GM007592
6 · The paper itself

Abstract

Epidemiological and experimental data implicate branched-chain amino acids (BCAAs) in the development of insulin resistance, but the mechanisms that underlie this link remain unclear. Insulin resistance in skeletal muscle stems from the excess accumulation of lipid species, a process that requires blood-borne lipids to initially traverse the blood vessel wall. How this trans-endothelial transport occurs and how it is regulated are not well understood. Here we leveraged PPARGC1a (also known as PGC-1α; encoded by Ppargc1a), a transcriptional coactivator that regulates broad programs of fatty acid consumption, to identify 3-hydroxyisobutyrate (3-HIB), a catabolic intermediate of the BCAA valine, as a new paracrine regulator of trans-endothelial fatty acid transport. We found that 3-HIB is secreted from muscle cells, activates endothelial fatty acid transport, stimulates muscle fatty acid uptake in vivo and promotes lipid accumulation in muscle, leading to insulin resistance in mice. Conversely, inhibiting the synthesis of 3-HIB in muscle cells blocks the ability of PGC-1α to promote endothelial fatty acid uptake. 3-HIB levels are elevated in muscle from db/db mice with diabetes and from human subjects with diabetes, as compared to those without diabetes. These data unveil a mechanism in which the metabolite 3-HIB, by regulating the trans-endothelial flux of fatty acids, links the regulation of fatty acid flux to BCAA catabolism, providing a mechanistic explanation for how increased BCAA catabolic flux can cause diabetes.

Indexed as

Amino Acids, Branched-ChainAnimalsFatty AcidsHumansHydroxybutyratesInsulinInsulin ResistanceMiceMice, Inbred NODMuscle, SkeletalObesityPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaTranscription FactorsAmino Acids, Branched-ChainFatty AcidsHydroxybutyratesInsulinPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPARGC1A protein, humanTranscription Factors

Identifiers

PMID26950361
PMCPMC4949205
OpenAlexW2294856235

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.